Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5′ non-coding region of the bcl-6 gene
- 1 April 2001
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 15 (4) , 628-634
- https://doi.org/10.1038/sj.leu.2402073
Abstract
Splenic marginal zone lymphoma (SMZL) has been recognized as a distinctive type of small B cell lymphoma, and defined on the basis of its morphological, phenotypic, clinical and molecular characteristics. In spite of this, the borders of the entity, the homogeneity of the cases and the presumably cell origin of SMZL remain controversial issues. The frequency of mutation in the 5′ non-coding region of the bcl-6 gene has been used as a marker of germinal center derivation, which may be used to establish the molecular heterogeneity of different non-Hodgkin lymphoma (NHL) types. This roughly parallels the characteristics and frequency of the somatic hypermutations found in the immunoglobulin heavy chain variable region (IgVH) genes. This study analyzed mutations of bcl-6 in the 5′ non-coding region in 22 SMZL cases and, for the purpose of comparison with different B cell subsets, in microdissected germinal centers, mantle zones and marginal zone subpopulations from reactive splenic lymphoid follicles. A majority of the SMZL cases studied, 19/22 (87%), bear unmutated bcl-6 gene, while mutation was only observed in 3/22 (13%) cases. Analysis of normal B cell subpopulations showed bcl-6 hypermutation in 3/10 (30%) germinal center clones, 5/14 (35%) marginal zone clones; and unmutated sequences in all clones derived from mantle cells. The frequency of these mutations in normal spleen confirms previous findings on the hypermutation IgVH process in normal B cell populations. The data presented here support the existence of molecular heterogeneity in this entity, and give additional results in favor of the hypothesis that, in spite of initial morphological observations, a significant proportion of SMZL cases could derive from an unmutated naive precursor, different from the marginal zone, and possibly located in the mantle zone of splenic lymphoid follicles. Thus the marginal zone differentiation of these tumors could be related more with the splenic microenvironment than it is to the histogenetic characteristics of the tumor.Keywords
This publication has 34 references indexed in Scilit:
- 7q31-32 Allelic Loss Is a Frequent Finding in Splenic Marginal Zone LymphomaThe American Journal of Pathology, 1999
- Splenic Marginal Zone LymphomaAdvances in Anatomic Pathology, 1997
- Clonal selection and learning in the antibody systemNature, 1996
- A Clinicopathological Study of 13 CasesThe American Journal of Surgical Pathology, 1995
- Analysis of somatic mutation in five B cell subsets of human tonsil.The Journal of Experimental Medicine, 1994
- Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express Vϰ genes with no or little somatic mutation throughout lifeEuropean Journal of Immunology, 1993
- Human tonsil intraepithelial B cells: a marginal zone-related subpopulation.Journal of Clinical Pathology, 1992
- Maturation of the immune response in germinal centersCell, 1991
- Normal Histology of the Human SpleenThe American Journal of Surgical Pathology, 1988
- Human Peyer's patches: an immunohistochemical study.Gut, 1986